Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 32,265 | 24,381 | 17,774 | 18,486 | 16,039 |
| Operating Income | -32,265 | -24,381 | -17,774 | -18,486 | -16,039 |
| Interest Expense | 1,027 | 1,004 | 1,000 | 0 | 0 |
| Other Income | 3,527 | 4,848 | 3,901 | 1,989 | 3,082 |
| Pre-tax Income | -29,765 | -20,537 | -14,873 | -16,497 | -12,957 |
| Net Income Continuous | -29,765 | -20,537 | -14,873 | -16,497 | -12,957 |
| Net Income | $-29,765 | $-20,537 | $-14,873 | $-16,497 | $-12,957 |
| EPS Basic Total Ops | -0.50 | -0.34 | -0.25 | -0.28 | -0.24 |
| EPS Basic Continuous Ops | -0.50 | -0.34 | -0.25 | -0.28 | -0.24 |
| EPS Diluted Total Ops | -0.50 | -0.34 | -0.25 | -0.28 | -0.24 |
| EPS Diluted Continuous Ops | -0.50 | -0.34 | -0.25 | -0.28 | -0.24 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.34 | -0.25 | -0.29 | -0.24 |
| EBITDA(a) | $-33,597 | $-25,795 | $-19,493 | $-20,224 | $-16,709 |